Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of vancomycin in critically ill patients undergoing continuous renal replacement therapy
TCTR20250608008Completed
- Sponsor
- This study does not have an external primary sponsor. The responsibility for initiating, managing, and financing the study lies solely with the principal investigator and their affiliated institution. The investigator ensures that the trial is properly registered and conducted according to all applicable regulations and guidelines.
- Start
- Apr 2025
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vancomycin in bacterial disease, sponsored by This study does not have an external primary sponsor. The responsibility for initiating, managing, and financing the study lies solely with the principal investigator and their affiliated institution. The investigator ensures that the trial is properly registered and conducted according to all applicable regulations and guidelines. Started Apr 2025; status: completed.
02
Drugs
vancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20250608008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250608008.